Category Stocks

180 Life Sciences (ATNF): has 300% upside

180 Life Sciences (ATNF): has 300% upside

We are three young guys with different backgrounds and areas of expertise, but with shared interests and ambitions. We have just started this journey and through our posts we aim to improve our Biotech knowledge and investment results, while providing…

Amgen’s (AMGN) next acquisition, Biocryst (BCRX)

Amgen's (AMGN) next acquisition, Biocryst (BCRX)

TLDR – $AMGN is targeting $BCRX for acquisition, which could bring other suitors knocking. E.g. Takeda Amgen is falling behind peers in their rare disease / orphan drug pipeline They tried fixing it by acquiring Alexion, $BCRX’s rival but failed Now a former surgeon general and **Amgen’s head of R&D, reg affairs…

Support.com (SPRT) continues to blast upwards

Support.com (SPRT) continues to blast upwards

Support.com (SPRT), which provides cloud-based software and services, was up nearly 60% to $31.20. The reason why is Support.com announced in March that it planned a reverse merger with privately held Greenidge Generation Holdings, which bills itself as “the first 100% carbon-neutral…

Why is Regencell Bioscience (RGC) going up today?

Why is Regencell Bioscience (RGC) going up today?

Regencell Bioscience (RGC) is an early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine (TCM) for the treatment of several neurocognitive disorders and degenerations, specifically Attention Deficit Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD).…